PAI Partners in talks to buy SGD Pharma: Reuters

PAI Partners is in talks to buy SGD Pharma, a French supplier of COVID-19 vaccine vials, from China Jianyin Investment, reported Reuters.

PAI Partners is in talks to buy SGD Pharma, a French supplier of COVID-19 vaccine vials, from China Jianyin Investment, reported Reuters. Citi and Rothschild advised PAI on the deal while Bank of America represented JIC.

Source: Reuters